BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18688229)

  • 1. Do biomaterials really mean business?
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):851-3. PubMed ID: 18688229
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrocarbons and renewable energy.
    Ringpfeil M
    Nat Biotechnol; 2004 Sep; 22(9):1077. PubMed ID: 15340466
    [No Abstract]   [Full Text] [Related]  

  • 3. White biotech and the financial crisis.
    Rabinovich M
    Biotechnol J; 2009 Aug; 4(8):1117-23. PubMed ID: 19685465
    [No Abstract]   [Full Text] [Related]  

  • 4. Japanese council urges reform of funding system.
    Triendl R
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract]   [Full Text] [Related]  

  • 5. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 6. Energy and biotechnology top Euro-Parliament's agenda.
    Butler D
    Nature; 1994 Jun; 369(6480):432. PubMed ID: 8202124
    [No Abstract]   [Full Text] [Related]  

  • 7. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 8. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 9. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 10. New tax credit program aims to revive ailing biotech research.
    Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
    [No Abstract]   [Full Text] [Related]  

  • 11. Big increase for MITI budget emphasizes energy technology.
    Swinbanks D
    Nature; 1992 Sep; 359(6390):4. PubMed ID: 1522883
    [No Abstract]   [Full Text] [Related]  

  • 12. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.
    Senker J; Enzing C; Joly PB; Reiss T
    Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596
    [No Abstract]   [Full Text] [Related]  

  • 13. Green fuels thrust.
    Bethencourt V
    Nat Biotechnol; 2009 Mar; 27(3):216. PubMed ID: 19270660
    [No Abstract]   [Full Text] [Related]  

  • 14. Fickle financing climate continues.
    Mitchell P
    Nat Biotechnol; 2001 Aug; 19(8):695-6. PubMed ID: 11479542
    [No Abstract]   [Full Text] [Related]  

  • 15. Translational science: a view from a biotechnology investor.
    Klausner R
    Sci Transl Med; 2010 Jun; 2(34):34ed3. PubMed ID: 20519715
    [No Abstract]   [Full Text] [Related]  

  • 16. SBIR program. Researchers fight against bigger slice to small business.
    Mervis J
    Science; 2009 Jul; 325(5936):18. PubMed ID: 19574355
    [No Abstract]   [Full Text] [Related]  

  • 17. Research parks feel the economic pinch.
    Ledford H
    Nature; 2009 Jun; 459(7249):896-7. PubMed ID: 19536226
    [No Abstract]   [Full Text] [Related]  

  • 18. Paying for research.
    Nature; 1992 Jan; 355(6356):96. PubMed ID: 1729654
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the stimulus working for you?
    Freeman R; Block F; Greenberg D; Levi M; Segal AM; Crow M; Teitelbaum MS
    Nature; 2009 Oct; 461(7266):876-8. PubMed ID: 19829353
    [No Abstract]   [Full Text] [Related]  

  • 20. How scientists can help to protect US homeland.
    McQueary CE
    Nature; 2003 Oct; 425(6957):451. PubMed ID: 14523418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.